EGFR and non-small cell lung carcinoma: Although prognostic nomograms including sex, age, operative approach, examined lymph nodes, vascular invasion, and EGFR gene mutation for stage IA NSCLC have been developed (Merritt et al., 2020; Yang et al., 2020; Cai et al., 2021), a prognostic model based on LUAD subtype and GGO component especially designed for stage IA IAC has been lacking.